Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
887.35
-16.20 (-1.79%)
< Home < Back

Natco Pharma invests Rs 120 crore in Visakhapatnam facility: Report

Date: 19-11-2016

Natco Pharma is reportedly planning to double the drug filings from the next financial year on the back of additional formulations capacity. The company is investing Rs 120 crore in the Visakhapatnam facility, which will be its first plant in Andhra Pradesh and it's new formulations manufacturing facility in Visakhapatnam is likely to be completed by 2017. 

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.